RxDoctor Payments Data

Camille Volking

Nurse Practitioner · Hayden, IDNPI 1578862017

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,053, 2.4 times the $435 reported in 2021. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,549in general payments, 2019–2025

Across 190 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$545
  • Bayer$421
  • Novartis$324
  • Amgen$309
  • Vifor Pharma, Inc.$302
  • Novo Nordisk$264
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,549100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,549 in reported general payments places this provider in the 90th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide21$21,567
TrulicityDulaglutide12$13,373
Sevelamer Carbonate12$1,806
Torsemide27$541
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$494
Ondansetron OdtOndansetron14$378
Hydromorphone Hcl15$277
Gabapentin30$200
Omeprazole11$194
Aripiprazole11$156
Carvedilol18$146
Pramipexole DihydrochloridePramipexole Di-Hcl15$134
Zolpidem Tartrate14$124
Lorazepam26$101
Levothyroxine Sodium17$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$264$21,56721 claims
Lilly USA, LLCTrulicity$121$13,37312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 570 nurse practitioner providers in Idaho.

Other nurse practitioner in Hayden

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →